Valsartan/Rosuvastatin Calcium

缬沙坦/瑞舒伐他汀钙

Report date: 2022/01/14 13:23:58

Base Information

Drug NameValsartan/Rosuvastatin Calcium
Drug Alias NameValsartan/rosuvastatin瑞舒伐他汀钙/缬沙坦Rosuvastatin Calcium/ValsartanRosuvastatin/ValsartanRovatitan
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsHyperlipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2016/01/01
Country/TerritorySouth Korea
CombinationsYes ValsartanRosuvastatin Calcium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC10BX10
Related LinksN/A